Kreos Capital

Since 1998, Kreos Capital has committed in excess of €5.7bn across +750 transactions, to more than 570 pan-European and Israeli high-growth companies in the technology and healthcare sectors. Today, they invest more than €800m a year and continue to enhance their product offering and presence in the market.

Throughout this time, Kreos Capital has been the consistent growth partner of choice, providing clarity and continuity for both management teams and equity sponsors looking for a long-term finance partner.

Since pioneering their investment strategy more than 25+ years ago, Kreos Capital has grown to become the leading growth debt provider in their target regions, with broad coverage and transaction history across Europe and Israel. In fact, Kreos Capital is now the only lender that can offer both local support and international coverage having invested in 18 countries and across a wide array of sectors.

Kreos Capital provides financing for companies across the wide spectrum of the Technology and Healthcare sectors. In Technology, they have invested across fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI and other sub-sectors, while in Healthcare, they have backed companies in areas such as drug & treatment development, medical products & devices, and healthcare tech.

Portfolio: Agnitio, Ably, Albireo, Bit.